SOLICITATION NOTICE
A -- Establishing a Protocol and Conducting a Pilot Effort for a Biorepository of Amyotrophic Lateral Sclerosis Specimens
- Notice Date
- 5/17/2011
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2011-N-13395
- Archive Date
- 6/16/2011
- Point of Contact
- Patrick W Gourley, Phone: 770-488-2898
- E-Mail Address
-
pgourley@cdc.gov
(pgourley@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- The Agency for Toxic Substances and Disease Registry (ATSDR) intends to compete and award a contract to develop a protocol and perform a pilot study in conjuction with the development of a biorepository for Amyotrophic Lateral Sclerosis (ALS) specimens. The purpose of this planned acquisition is to establish a protocol for the creation of a biorepository of specimens from persons with ALS enrolled in the National ALS Registry and to conduct a pilot effort based upon the protocol developed. Because the genetic causes of ALS are largely unknown, ATSDR is seeking expert guidance on establishing a biorepository of samples that are linked with ALS patients enrolled in the National ALS Registry. ATSDR is particularly interested in blood and tissue samples. While there are other biorepositories currently in existence that contain specimens from persons with ALS, these biorepositories are often limited and target select groups (e.g., military veterans with ALS). Submission of specimens for this biorepository would be open to all U.S. citizens and Legal Residents of the U.S with ALS enrolled in the congressionally mandated National ALS Registry. The ability to connect the biological material to information about risk factors and data about medical treatment will make the biorepository especially valuable to ALS researchers. Although biorepositories vary in scope and size, it is anticipated that the successful contractor will create a protocol that can be used to develop a biorepository of ALS human samples to complement the National ALS Registry. Before the protocol is developed, the Contractor should convene a group of experts in registries, surveillance, and/or neurological diseases to determine the best practices for establishing a biorepository as described. The Contractor will test and finalize the approved protocol by conducting a pilot effort to collect biological samples from at least 100 Registry enrollees. Full and open competition will be used in soliciting offers for this requirement. All responsible sources may submit a proposal which shall be considered by the agency. Solicitation 2011-N-13395 will be posted in FedBizOpps on or about June 01, 2011 and the scheduled due date for proposals will be approximately 30 days after posting the solicitation.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2011-N-13395/listing.html)
- Place of Performance
- Address: Contractor's facility, United States
- Record
- SN02450350-W 20110519/110517235040-5f54af7d7d54b9626e2eb5798e767a27 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |